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Physical forces play a major role in the organization of developing
tissues. During vascular development, physical forces originating
from a fluid phase or from cells pulling on their environment can
alter cellular signaling and the behavior of cells. Here, we observe
how tissue deformation spatially modulates angiogenic signals
and angiogenesis. Using soft lithographic templates, we assemble
three-dimensional, geometric tissues. The tissues contract autono-
mously, change shape stereotypically and form patterns of vascular
structures in regions of high deformations. We show that this
emergence correlates with the formation of a long-range gradient
of Vascular Endothelial Growth Factor (VEGF) in interstitial cells,
the local overexpression of the corresponding receptor VEGF
receptor 2 (VEGFR-2) and local differences in endothelial cells
proliferation. We suggest that tissue contractility and deformation
can induce the formation of gradients of angiogenic microenviron-
ments which could contribute to the long-range patterning of the
vascular system.
vascular patterning ∣ blood vessels ∣ morphogenesis ∣ mechanical forces
Tissue deformation influences the development of the vascula-ture in the embryo (1) and in the contracting wound (2).
Current models suggest that physical forces originating from the
blood (3), from cells pulling on neighboring cells (4), and on the
Extra Cellular Matrix (ECM) (5) distort cellular membrane re-
ceptors and cytoskeletal elements, modulate biochemical signal-
ing pathways and the behavior of endothelial and smooth muscle
cells (6). However it is not known whether physical forces can
spatially modulates angiogenic signals and contribute to vascular
patterning.
Angiogenic molecules orchestrate cellular behaviors (growth,
apoptosis, mobility) whose local differentials underlie morpho-
genesis and the formation of vascular patterns. The Vascular
Endothelial Growth Factor (VEGF) is a highly vascular-specific
signaling molecule. The principal component of the VEGF mo-
lecules is VEGF-A, it binds the Receptor Tyrosine Kinase VEGF
Receptor 2 (VEGFR-2). VEGFR-2 activates multiple downstream
signaling molecules including Mitogen-Activated Protein Kinases
(MAPKs), Phosphoinositide 3-Kinases, PKB (Protein Kinase B) or
small GTPases (7). As a result, endothelial cells (EC) proliferate,
migrate, degrade the ECM, and modulate endothelium permeabil-
ity (7). The tight spatial regulation of the VEGF-A/VEGFR-2
system is thus essential to control vascular development. Interest-
ingly, the growth and apoptosis of EC (8, 9) and the expression of
VEGFR-2 (3, 10) aremodulated by physical forces. This regulation
might occur via the Rho inhibitor p190RhoGAP and the balance
between antagonist transcriptions factors TFII-I (also known as
GTF2I) and GATA-2 (5).
Vascular patterning is governed by oxygen deficiency (hypoxia)
which controls the local production of VEGF via Hypoxia-
Inducible Factor [HIF1α, (11)]. A gradient of VEGF overlays a
gradient of hypoxia which orientates, attracts, and induces pro-
liferation of new blood vessels (12). Upon irrigation of the tissue,
hypoxia decreases and so does the production of VEGF. This
patterning mechanism does not imply a role for the physical de-
formation of tissues.
Microfabricated platforms are powerful tools to recapitulate
and systematically manipulate simplified cases of tissue morpho-
genesis with an intermediate complexity between 2D cell culture
and model organisms (13). In this manuscript, we show a simple,
cost-effective, widely applicable platform to assemble 3D, free-
standing tissues. We manipulate tissue deformation and observe
its impact on the formation of gradients of angiogenic microen-
vironments and angiogenesis.
Results
Self-Remodeling Microfabricated Tissues. We mimicked the early
events of angiogenesis using a coculture of two cell types: human
Umbilical Vein Endothelial Cells (hUVEC) as a well character-
ized EC type (14) and human Mesenchymal Stem Cells (hMSC)
which can generate forces (15), produce VEGF-A (16) thus mi-
micking some aspects of interstitial stromal cells. Our microarray
data, along with others (17), show that hMSC do not significantly
express VEGFR-2. Indeed, in this coculture, immunofluores-
cence of VEGFR-2 was restricted to hUVEC (Fig. S1). We pre-
viously showed that this coculture supports the formation of a 3D
network of PECAM-1þ vascular structures (VS) (18).
We used conventional soft lithography and micromolding
to form nonadherent agarose templates (Fig. 1A). On these tem-
plates, we assembled tissues by sequentially aggregating cells into
microscale clusters and millimeter-scale tissues (Fig. 1A). Result-
ing tissues are free-standing and biomaterial-free and can easily
be manipulated (Fig. 1B). Tissues have an initial projection area
of 1 mm2 and a height of 250 μm. Over five days of culture,
tissues contracted autonomously, deformed stereotypically, and
finally stabilized their shapes (Fig. 1C, Fig. S2). Disc-shaped
tissues deformed isotropically (Fig. 1C, first row) whereas square-
shaped tissues deformed anisotropically. Corners displaced and
deformed more as compared to sides (Fig. 1C, second row,
Fig. S2, p ¼ 0.0015, n ¼ 10). To compensate, we designed star-
shaped tissues which progressively deformed into a square
(Fig. 1C, third row). This anisotropic deformation suggested a
heterogeneous distribution of internal forces. It was previously
modeled that boundaries and sharp geometries generate greater
forces as compared to regions away from these boundaries (9,
19, 20). Based on macroscopic behavior and cellular density, we
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estimated the local strain to be twofold higher in tissue corners as
compared to tissue centers (Fig. S3).
Endothelial Cell Sprouting and the Formation of Patterns of Vascular
Structures. In microscale clusters (first step, Fig. 1A, top row),
hUVEC and hMSC separated into a core of PECAM-1þ cells
(asterisk, Fig. 1D) and an external layer of PECAM-1− cells.
Sorting probably occurred according to differences in cellular
affinity (strength of adhesion molecules) and cortical tension
which determines cell association (21). When pooled (second
step, Fig. 1A, bottom row), microscale clusters fused with neigh-
bors via the transient and peripheral expression of filamentous
actin (F-actin, Fig. 1D, 24 h, Fig. S4). After 24 h, PECAM-1þ
cells became F-actin intense, sprouted into VS (Fig. 1E) which
branched and formed cord-like structures including few lumens.
VS did not undergo full tubulogenesis but rather form small,
interspersed lumens as described previously (18). This model
is relevant to the early stage of vascular morphogenesis (13, 18,
20, 22). Angiogenic factors were produced locally by cells cul-
tured in serum-free medium without any growth factors. Tissues
contracted and deformed autonomously (no external forces
applied). This model allows to couple endogenous tissue contrac-
tility and deformation to the formation of VS.
Upon tissues contraction and deformation (day 5), VS had
formed preferentially in peripheral regions (Fig. 1F). The prefer-
ential formation of VS was consistently observed in disc-, star-,
and triangle-shaped tissues (Fig. 1F, Fig. S5). In star- and triangle-
shaped tissues, VS formed at higher density in corners as
compared to sides (p ¼ 0.0026 and p ¼ 0.002 respectively,
Fig. S5). We concluded that VS formed preferentially in regions
of higher deformation.
Actin-Myosin Regulates Tissue Deformation. We impaired tissue
contractility by blocking force-generating elements in cells. Non
muscle Myosins II A, B, and C (NMM II) and F-actin are likely to
be main generators of forces in hMSC (15). Blebistatin blocks
the activation of NMM II ATPase and impairs its interaction with
F-actin (23). Y27632 suppresses p160ROCK (Rho associated
coiled-coil containing protein kinase) thus inhibiting the phos-
phorylation of Myosin Light Chain and the formation of F-actin
stress fibers (23). Upon culture with Blebistatin or Y27632 alone,
tissues contracted and deformed similarly to controls. However,
upon exposure to the combination of the two inhibitors, tissues
rapidly relaxed from 78% to 84% of their initial area (Fig. 2A and
B, see black arrow, p ¼ 0.0002, n ¼ 10). This relaxation demon-
strated an internal tensional state generated by the actin-myosin
complex. Upon inhibition of actin and myosin, tissue contraction
was later impaired (Fig. 2 A and B, 144 h, 70% of the initial pro-
jected area vs. 58%, p ¼ 6.10−7, n ¼ 10). Tissue contraction was
impaired but not stopped which implies a possible contribution of
other cytoskeletal components or mechanisms. Based on cellular
density and macroscopic behavior, we estimated the overall strain
to be twofold lower when contraction was impaired (Fig. S3).
Tissue Contraction Regulates the Gene Expression of VEGF-A and
VEGFR-2. To investigate the molecular changes underlying tissue
contraction, we compared the expression of angiogenic genes in
tissues undergoing normal and impaired contraction. Expression
levels of ECM genes (collagen type I, laminin α1, laminin β5) and
matrix-degrading metalloproteinase genes (MMP9, MMP13) re-
mained unchanged. However, expression levels of VEGF-A and
VEGFR-2 were higher in contracting tissues as compared to
tissue with impaired contraction (day 3, Fig. 2C). We tested
the contribution of VEGF to the formation of the VS by adding
a scavenging antibody to the culture medium. Addition of the
VEGF antibody dramatically reduced the formation of VS,
demonstrating thus a critical dependence of VS upon VEGF
(Fig. 2D). In a control assay, we showed, in cell pellets, that the
VEGF antibody prevented the formation of VS by decreasing
cellular proliferation (Fig. S6). We concluded that VEGF was
Fig. 1. Microfabricated tissues deform autonomously and form vascular
structures in regions of high deformations. (A) Arrays of 3D millimeter-scale
tissues are assembled by sequential aggregation of cells and microscale cell
clusters in nonadherent micromolded wells. Arrays are replicated from
PDMS stamps (transparent arrays) into agarose (pink arrays) and inserted
in standard tissue culture plates. (B) Resulting tissues are 3D, millimeter-scale,
free-standing and biomaterial-free (scale bar, 500 μm). (C) Microfabricated
tissues contract, deform isotropically (top row) or anisotropically (second/
third rows), and finally stabilize their shape (scale bar, 500 μm). (D–E)
PECAM-1 is depicted in red and F-actin in green. Microscale cell clusters of
hUVEC and hMSC first spontaneously form a PECAM-1þ core [D, asterisk,
(scale bar, 100 μm)] and a PECAM-1− external layer. Microscale cell clusters
generate an F-actin intense interface upon fusion with neighbors (24 h).
(E) After 24 h, PECAM-1þ cells are F-actinþ and start sprouting [E, (scale
bar, 100 μm)]. (F) Upon tissue deformation, PECAM-1 immunostaining reveals
a preferential formation of VS in regions of high deformations [tissue
periphery and corners, (scale bar, 500 μm)].
Fig. 2. Tissue deformation is actin-myosin dependent and regulates VEGF-A
and VEGFR-2 expression. (A, B) The combined inhibition of non muscle Myo-
sin II (Blebistatin) and Rho associated protein kinase p160ROCK (Y27632) at
24 h (see black arrow in B) induces a relaxation of the internal tissue tension
(28 h) and impairs tissue deformation (150 h). (A, top row) Tissue deformation
results in local compaction (nuclear, DAPI staining) and a concentration of
force-generating elements [nm Myosin II and F-actin immunofluorescence,
(scale bar, 100 μm)] in regions of high deformations. (A, bottom row) This
effect is impaired when deformation is impaired. (C) Upon impairment of
tissue deformation, expression levels of VEGF-A and VEGFR-2 are lower. ECM
related genes remain similar. Standard deviations, n ¼ 3. (D) The formation
of VS is strongly impaired when a VEGF scavenging antibody is added to the
culture medium (PECAM-1 immunofluorescence).

















necessary for the formation of VS and that tissue contraction did
not directly induce the formation of VS.
Local Tissue Compaction Partially Contributes to the Formation of Vas-
cular Patterns. We then asked if the anisotropic deformation of
tissues resulted in local changes in cellular density. Upon tissue
contraction and deformation, cellular density gradually increased
from the tissue center to the periphery (Fig. 2B, 3A). This gra-
dient was impaired when contraction was impaired (Fig. 2B, 3A)
and correlated with an increase of NMM II and F-actin (Fig. 2B).
We then assessed the contribution of local tissue compaction
on the local formation of VS. Cellular density was homogeneous
in the tissue center but gradually increased in the peripheral
regions (Fig. 3 A and B). In parallel, the density of VS increased
by 4.8-fold and the density of VS/nucleus increased by 2.5-fold
(Fig. 3 A and B). When tissue contractility was impaired, the
gradient of cellular density was impaired and VS grew homoge-
neously throughout the tissues (Fig. 3 A and B). Higher local cel-
lular density directly contributed to 48% of the increased density
of VS (Fig. 3D). This measurement assessed that local tissue
compaction induced more than a direct concentration of VS and
suggested a more complex role for endogenous contractile forces.
Indeed, upon impairment of tissue contraction, the contribution
of cellular density increased to 73% (Fig. 3D).
Tissue Contraction Induces Changes in the Phenotype of Vascular
Structures. The phenotypes of VS changed across the tissue. In re-
gions of high deformations, VS were thin, shaped and elongated
perpendicular to the tissue displacement (Fig. 3C, left, white arrow
shows the corner-to-center direction). This orientation of VS
correlates with previous reports describing an elongation of EC
perpendicular to externally applied mechanical stress (24). When
endogenous contractility was impaired, VS grew homogeneously,
were wider, tortuous, and randomly oriented (Fig. 3C right).
Vascular morphogenesis can be driven by local tissue hypoxia
which regulates the production of multiple angiogenic factors
(11). Tissues were designed with dimensions alleviating the
formation of a hypoxic environment. However, we tested the pos-
sible formation of local hypoxic environments by looking at the
distribution of HIF1α which translocates to the nuclei of hypoxic
cells to activate angiogenic genes (11). Here, HIF1α was cytoplas-
mic and homogeneously expressed across the tissues. The cyto-
plasmic expression of HIF1a suggests that hypoxic levels are low
and homogeneous across the tissues (Fig. S7).
Tissue Contractility Locally Regulates the Expression of VEGFR-2. EC
are mechanosensitive cells (10, 20) which can transcriptionally
regulate the expression of the VEGFR-2 receptor based on
the mechanical properties of the microenvironment (5, 10).
VEGFR-2 mediates the major growth and permeability roles
of VEGF-A (5). Based on the differences in VEGFR-2 gene ex-
pression level (Fig. 2C), we tested the possibility that EC respond
to tissue deformation by spatially modulating the expression of
VEGFR-2. VEGFR-2 expression was restricted to PECAM-1þ
cells (Fig. S1), a cell-cell adhesion molecule which is thought to
convey mechanical forces but whose expression is not regulated
by mechanical forces (3). Upon tissue contraction, PECAM-1þ
cells in regions of high deformation expressed a higher level
of VEGFR-2 per PECAM-1þ area (8.5-fold increase) than
cells in the central region (p ¼ 0.026, n ¼ 15, Fig. 4 A and C).
When contraction was impaired, the expression of VEGFR-2∕
PECAM-1þ area decreased and became homogenous across the
tissue (Fig. 4 A and C). This local increase in VEGFR-2 expres-
sion correlated with the formation of clusters of high fluorescent
intensity at the cellular membrane (Fig. S1). This observation is
consistent with previous reports describing the formation of
VEGFR-2 complexes in response to mechanical shear stress
(10). The region of VEGFR-2 overexpression was very localized
(last 20% of the center to periphery distance). We concluded,
based on the mRNA expression level (Fig. 2C) and on the differ-
ential in immunofluorescent intensity, that endogenous tissue
contractility induced a quantitative and spatial regulation of
the VEGFR-2 receptor.
Tissue Contractility Regulates the Formation of a Gradient of VEGF.
Based on the differences in VEGF-A gene expression level
(Fig. 2C) and because hMSC are mechanosensitive cells (15), we
tested the possibility that tissue contractility spatially regulated
the expression of VEGF-A proteins. We cut the tissue corners
and observe that the expression of VEGF-A mRNA was 1.5-fold
higher in corners as compared to centers (n ¼ 3, p ¼ 0.07,
Fig. S8A). Immunofluorescent staining (all VEGF isoforms)
revealed the formation of a gradient of VEGF: fluorescent inten-
sity in tissue corners was twofold higher than in tissue centers
(Fig. 4 B, D and E). When contraction was impaired, the gradient
of VEGF fluorescent intensity was impaired (Fig. 4E) and the
total fluorescent intensity expressed in the tissue decreased by
twofold (p ¼ 0.032, n ¼ 3, Fig. 4F). Upon normalization to the
number of nuclei, cells in the regions of high deformation had
higher fluorescent intensity as compared to cells located in the
center (p ¼ 0.034, n ¼ 15, Fig. 4F). We assessed the validity
of the measurement of fluorescent intensity using a 2D assay:
Deferoxamine [DFO, a HIF-1a inducer (25)] induces a twofold
increase in VEGF imunofluorescent staining intensity. This in-
crease correlated with a fivefold increase in the intracellular pro-
duction of VEGF (ELISA assay for isoforms 165 and 121 on cell
lysate, Fig. S9). We further assessed the role of cell-generated
forces on the production of VEGF proteins in cell pellets (0.5
million cells, 92% hMSC, and 8% hUVEC). Pellets whose con-
traction was impaired produce 1.6-fold less VEGF proteins than
pellets undergoing normal contraction (Fig. 4G, ELISA assay on
culture medium, n ¼ 3, p < 0.001). These observations suggest
Fig. 3. Local tissue compaction partly contributes to the local formation
of Vascular Structures. (A, B) VS form at a higher density in regions of high
deformation (A, B, left, from the center to periphery: 2.5-fold increase in VS/
nucleus). When tissue contraction and deformation are impaired, VS grow
homogeneously throughout the tissue (A, B right). (B, C) Tissue deformation
induces local tissue compaction (B, number of nuclei, top row) and the for-
mation of thin VS including some lumens (asterisk, C left). VS preferentially
elongate perpendicular to tissue displacement (A, C, arrows show the direc-
tion of displacement). This phenotype and directionality are impaired when
contraction and deformation are impaired [A, C, right, (scale bars, are
100 μm)]. (D) Local tissue compaction partially contributes to the local forma-
tion of VS. The local increase in cellular density accounts for 48% of the local
increase of VS (D, left, normal contraction). This contribution increases to
73% when contraction is impaired (D, right).
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that tissue contraction regulates the expression of VEGF. We
concluded that tissue deformation regulates the formation of a
VEGF gradient formed via a local tissue compaction and a local
regulation of VEGF expression.
Cell-Generated Forces Modulate the Production of ECM Binding Iso-
forms VEGF189 and VEGF189. The production of VEGF is regulated
via mRNA splicing which induces the formation of various iso-
forms (26). VEGF isoforms differ in heparin-binding domains
(HBD) which affects their capacity to bind to cellular membranes
and ECM. Such property could modulate their localization in the
extracellular space (26) and is suited for the creation of molecular
gradients (27). VEGF121, the shortest isoform, lacks HBD, is
weakly acidic and freely diffusible upon secretion. VEGF189, a
longer isoform, has two HBD and is mostly sequestrated in the
ECM and at the cell surface. VEGF165 possesses intermediate
properties, has a moderate affinity for heparin and is both soluble
and bounded (26). Using isoform-specific polymerase chain reac-
tion, we observed in cell pellets that VEGF165 and VEGF189
expression was 2.5-fold higher upon normal contraction as com-
pared to impaired contraction (Fig. 4H, p < 0.001, n ¼ 3). On the
opposite, the expression of VEGF121 and VEGF145 remained
unchanged. This observation suggests that tissue deformation influ-
ences the expression of longer, heparin-binding VEGF isoforms.
We speculate that the ECM and cellular-binding properties of the
two isoforms reinforce the formation of the VEGF gradient by pre-
venting protein diffusion.
Tissue Contractility Induces Local Proliferation of Endothelial Cells.
Because tissue deformation regulates the microenvironmental
concentration of VEGF-A and VEGFR-2 and because VEGF-A
is a potent mitogen acting via VEGFR-2, we quantified the local
proliferation of EC. Using pulsed exposure to EdU (5-ethynyl-2’-
deoxyuridine) (5-ethynyl-2’-deoxyuridine exposure over twelve
hours, daily time point over five days), we observed that EdUþ
cells were limited to PECAM-1þ cells. EdUþ cells represented
0.3 to 1% of the total cell number (Fig. S10). Upon tissue defor-
Fig. 4. Tissue contractility spatially regulates the expression of VEGF and VEGFR-2. (A, C) Upon tissue contraction and deformation, VEGFR-2 is expressed at
higher levels in regions of high deformation (A, C, left, VEGFR-2 fluorescent intensity∕PECAM-1þ area, 3.5-fold increase, n ¼ 15, p ¼ 0.026). This local increase
in VEGFR-2 is impaired when tissue contractility is impaired [A, C right, (scale bars, are 100 μm)]. In regions of high deformation, VEGFR-2 forms clusters at the
cellular membrane of EC (Fig. S1). (B,D, E, F) Upon normal contraction, a gradient of VEGF forms via local compaction and graded production. (B–E) Fluorescent
intensity is twofold higher in regions of high deformation (B–E, left; C is a close up of corner regions). This observation is confirmed at a mRNA level (Fig. S8A).
The gradient of VEGF is impaired when tissue contractility is impaired (B, E, right). (F) Upon normalization to the number of nuclei, the fluorescent intensity of
VEGF/nucleus is higher in regions of high deformation (p ¼ 0.034) and higher in contracting tissues than in tissues whose contraction is impaired (p ¼ 0.032,
see also Fig. S8B). (G) The production of VEGF (ELISA assay) is higher in cell pellets undergoing normal contraction than when contraction is impaired
(p < 0.001). (H) Impaired contraction specifically affects the expression of VEGF isoforms 165 and 189 (ECM-binding isoforms). Expression levels of isoforms
121 and 145 (non-ECM-binding isoforms) remain unchanged (p < 0.001).
Fig. 5. Tissue deformation induces a local differential on endothelial cell
proliferation. (A, B) EdU pulsed incorporation shows a higher percentage
of proliferating EC in regions of high deformations. This local differential in
EC proliferation is abolished when tissue deformation is impaired. (C) VS in
regions of high deformation include a higher number of EC in deforming
tissues as compared to tissues whose deformation is impaired.

















mation, VS in regions of high deformation included more prolif-
erating cells (EdUþ) than VS in the tissue center (Fig. 5 A and B,
28% vs. 8%, p ¼ 0.016). When deformation was impaired, the
density of proliferating cells was lower (8%) and their distribution
homogenous (Fig. 5 A and B). Finally, we quantified the number
of PECAM-1þ cells per VS. Upon normal deformation, the
number of PECAM-1þ cells in VS increased from tissue center
to corner (Fig. 5C). When contraction was impaired, the number
of PECAM-1þ cells in VS remained unchanged (Fig. 5C). VS
in tissue corners included more PECAM-1þ cells upon normal
contraction as compared to impaired contraction (Fig. 5C). We
concluded that VS in regions of high deformation formed via
a higher EC proliferation which resulted in a higher number
of cells per VS.
We propose that tissue deformation can spatially modulate
the expression of VEGF-A and VEGFR-2, and contribute to the
formation of patterns of VS by inducing local differentials in EC
proliferation.
Discussion
Vascular patterns can emerge from the spatial regulation of
angiogenic signals including the concentration of and the EC
sensitivity to mitogens (5, 28). Here, we suggest that tissue con-
traction and deformation can spatially modulate cellular density,
the local expression of VEGF-A and VEGFR-2, and induce a
local differential in EC proliferation.
Morphogen gradients form by regulated production, retention,
controlled release, diffusion, and degradation (12, 29). Our data
suggest that interstitial cells can form gradients of angiogenic
microenvironments via local tissue compaction and a local regu-
lation of VEGF signaling. The regulation of ECM-binding VEGF
isoforms (VEGF165 and VEGF189) by tissue contractility could
prevent VEGF protein diffusion and reinforce molecular gradi-
ents (30).
The agonist activity of VEGF on VEGFR-2 (i) guides the
sprouting of the cell situated at the tip of the VS via local gra-
dients (filopodia/lamellipodia extension along a differential of
concentration) and (ii) induces the proliferation of the following,
stalk EC based on local concentration (absolute concentration)
(12). Our observations suggest that the higher local concentration
of VEGF and of the local expression of the corresponding recep-
tor VEGFR-2 induced a local differential in the proliferation
of the stalk cells. Previous studies revealed that EC shape and
cytoskeletal tension regulates a discrete cell cycle check-point at
the G1/S border. The sensitivity to a mitogen is partly modulated
by mechanical factors via the cdk inhibitor p27 and the activator
cyclin D (31, 32). We speculate that the local proliferation of EC
results from an appropriate combination of cytoskeletal tension
and VEGF-A/VEGFR-2 density.
This experiment links tissue contraction and deformation to
the formation of a gradient of angiogenic microenvironments.
This correlation might explain, in further investigations, how
contractile forces generated within a tissue or between adjacent
tissues might have a long-range control over capillary formation.
These findings may be relevant in wound healing -vascular
morphogenesis was reported to be mechanically driven by the
contracting wound (2)-, or in cancer biology -tumors are depen-
dent on angiogenesis and stiffer than normal tissues due to an
elevated endogeneous tension (33).
Self-organization can emerge from tissue contractility and
geometry. Such properties induce an heterogeneous tissue defor-
mation and pattern the behavior of cells. We suggest that tissue
contractility and deformation can modulate the formation of
gradients of angiogenic microenvironments and angiogenesis.
We speculate that such a mechanism might contribute to the
long-range patterning of the vascular system.
Methods
Agarose Chips. Micropatterned agarose chips for nonadherent cell culture
were formed by replica molding. Patterned elastomeric stamps of poly
(dimethylsiloxane) (PDMS; Sylgard 184, Dow Corning) were replicated from
either etched silicon wafers or SU-8/silicon wafers. PDMS stamps were used
to routinely replicate the microstructures in 4% agarose.
Coculture. A coculture of 92% hMSC and 8% huvEC was used for all experi-
ments. The culture medium for the coculture (Exp. Medium) was serum-free
and composed of Dulbecco’s Modified Eagle’s Medium supplemented with
10−7 M dexamethasone, 50 mg∕mL ascorbate 2-phosphate, 40 mg∕mL pro-
line, 100 mg∕mL pyruvate, and 50 mg∕mL ITS 1 Premix (Becton-Dickinson,
MA: 6.25 mg∕mL insulin, 6.25 mg∕mL transferrin, 6.25 ng∕mL selenious acid,
1.25 mg∕mL bovine serum albumin, 5.35 mg∕mL linoleic acid).
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